RIGEL PHARMACEUTICALS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

RIGEL PHARMACEUTICALS, INC. (RIGL) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $95.91 million as of 2016-03-31, per its 10-Q filed 2016-05-03.

Discontinued › Notes › Investments › Debt and Equity Securities

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2016-05-03

2016-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $95.91M.
2015-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $130.03M.
2014-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $123.07M.
2014-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $124.84M.

Period end	Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
2016-03-31	$95.91M 10-Q · filed 2016-05-03
2015-03-31	$130.03M 10-Q · filed 2015-05-07
2014-09-30	$123.07M 10-Q · filed 2014-11-04
2014-06-30	$124.84M 10-Q · filed 2014-08-05

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Apnimed, Inc. (APMD)	United States	$0.899B
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
Arbutus Biopharma Corp (ABUS)		$0.965B	6.19